ENLV
Companies
NASDAQ
Enlivex Therapeutics Ltd.
Health Care
$1.05
-$0.07 (-6.41%)
Price Chart
Overview
About ENLV
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Market Cap
$28.0M
Volume
90.5K
Avg. Volume
217.3K
P/E Ratio
-1.5332758
Dividend Yield
0.00%
Employees
56.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.76
Moderate Correlation
Volatility
High (0.84)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ENLV shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025